Bal Pharma Limited continues to strengthen its commitment to the UN Sustainable Development Goals (SDGs) through focused sustainability initiatives. The company is nearing completion of its 1.5 MW captive solar power project. To ensure reliable tracking, ABT meters have been installed for precise monitoring and adjustment of solar power usage.
In parallel, Bal Pharma Limited has partnered with rePurpose Global, committing to recover 60,000 kg of plastic waste in India equivalent to roughly 4.12 crore Paracetamol blister strips. This initiative supports responsible waste management and reinforces the company's efforts toward a circular economy.
These initiatives align with and contribute to the following UN Sustainable Development Goals
Disclaimer. Content is not approved by the UN & doesn't reflect their views
In FY 2024–25, Bal Pharma conducted its first Materiality Assessment in line with GRI Standards 2021. The exercise involved industry benchmarking, global ESG trend analysis, and internal stakeholder consultations. Material topics were prioritized based on business impact and stakeholder relevance. The outcomes guide Bal Pharma’s sustainability strategy, disclosures, and performance monitoring.
Bal Pharma Limited has partnered with rePurpose to recover 60,000 kg of plastic waste in India as part of its ESG commitment. The initiative focuses on plastic collection, recycling, and awareness to reduce environmental impact. This partnership supports responsible waste management and contributes to a more sustainable future.
At Bal Pharma, science is our foundation and care is our commitment. Inspired by India’s philosophy of balance, responsibility, and collective well-being, we work to improve quality of life through accessible and responsible healthcare. As our presence grows across markets and therapeutic areas, we are strengthening our focus on environmental, social, and governance (ESG) practices. Our inaugural Sustainability Report reflects our commitment to managing impact responsibly, operating transparently, and creating long-term value for all stakeholders. Rooted in care and guided by purpose, we continue our journey towards sustainable growth and shared progress.
Bal Pharma policies form the backbone of our governance framework. Built on global benchmarks, they cover critical areas like environment, health and safety, fair labor, data privacy, and anti-bribery, human rights ensuring we operate ethically and transparently across all geographies.
At Bal Pharma, we are committed to making a positive and lasting impact on society through meaningful community initiatives. Our CSR efforts focus on strengthening access to healthcare, supporting inclusive well-being, and promoting education for underprivileged communities.
We have contributed to improving primary healthcare infrastructure by donating essential medical equipment to local healthcare centers. To support education, we provide scholarships to economically disadvantaged students, enabling them to continue their academic journey. We also extend medical and medicine support to children with intellectual and developmental disabilities, fostering inclusive healthcare and dignity of care.
Bal Pharma supports education in the local community by providing scholarships to economically disadvantaged students studying at the Adarsh Group of Institutions, in association with Adarsh Vidyasangh.
Bal Pharma, in association with Rotary Bangalore Brigades, donated essential medical equipment to primary healthcare centers, supporting improved access to basic healthcare services for local communities.
Bal Pharma supports the medical and medicine expenses of children with intellectual and developmental disabilities at Mathrushree Manovikasa Kendra, contributing to inclusive healthcare and community well being.
As part of our community health initiatives, Bal Pharma supported one month of free dialysis treatment for patients with kidney malfunction, in association with Jain Mission Trust, Chikkaballapur. This initiative aimed to improve access to essential, life-sustaining healthcare for patients in need.